Top cancer specialists are urging men to look past the common symptoms of aging and recognize these critical warning signs. It’s often said that if you have your health, you have everything, and there ...

Transdermal estradiol (tE2) is an alternative to luteinizing hormone–releasing hormone (LHRH) agonists as androgen-deprivation therapy in patients with prostate cancer. With tE2, testosterone is ...

Pfizer is eyeing an earlier use of its PARP inhibitor Talzenna after a positive phase 3 trial in metastatic hormone-sensitive prostate cancer (mHSPC). The phase 3 Talapro-3 trial met its primary ...

Patches typically used to alleviate symptoms of menopause in women could offer a new treatment pathway for a specific type of prostate cancer, according to a new study. Researchers at University ...

A 55-year-old man with a history of hypertension, type 2 diabetes, and hyperlipidemia presents with an evolving rash and painful finger lesions. Case by Dr Fathy et al.